Evidence map›Paper›PMID 37169496›Full record

Trial reportBMJ open2023

Feasibility randomised controlled trial of online group Acceptance and Commitment Therapy for Functional Cognitive Disorder (ACT4FCD).

Norman Poole, Sarah Cope, Serena Vanzan, Aimee Duffus, Nadia Mantovani, Jared Smith, Barbara M Barrett, Melanie Tokley, Martin Scicluna, Sarah Beardmore and 3 more

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Norman PooleDeptartment of Neuropsychiatry, South West London and Saint George's Mental Health NHS Trust, London, UK norman.poole@gmail.com.ORCID 0000-0002-3187-6430
Sarah CopeDeptartment of Neuropsychiatry, South West London and Saint George's Mental Health NHS Trust, London, UK.ORCID 0000-0002-1672-9459
Serena VanzanReseach and Development Deptartment, South West London and St George's NHS Mental Health Trust, London, UK.
Aimee DuffusReseach and Development Deptartment, South West London and St George's NHS Mental Health Trust, London, UK.
Nadia MantovaniSt George's University of London, London, UK.ORCID 0000-0002-0352-7444
Jared SmithSt George's University of London, London, UK.
Barbara M BarrettKing's Health Economics, King's College London, London, UK.
Melanie TokleyEastern Community Mental Health Centre, Adelaide, South Australia, Australia.
Martin SciclunaReseach and Development Deptartment, South West London and St George's NHS Mental Health Trust, London, UK.
Sarah BeardmoreReseach and Development Deptartment, South West London and St George's NHS Mental Health Trust, London, UK.
Kati TurnerSt George's University of London, London, UK.
Mark EdwardsDepartment of Neuroscience, Institute of Psychiatry, Psychology, and Neuroscience (IOPPN), London, UK.
Robert HowardUniversity College London Division of Psychiatry, London, UK.

Funding

Department of Health NIHR202743
6 · The paper itself

Abstract

introductionFunctional cognitive disorder (FCD) is seen increasingly in clinics commissioned to assess cognitive disorders. Patients report frequent cognitive, especially memory, failures. The diagnosis can be made clinically, and unnecessary investigations avoided. While there is some evidence that psychological treatments can be helpful, they are not routinely available. Therefore, we have developed a brief psychological intervention using the principles of acceptance and commitment therapy (ACT) that can be delivered in groups and online. We are conducting a feasibility study to assess whether the intervention can be delivered within a randomised controlled trial. We aim to study the feasibility of recruitment, willingness to be randomised to intervention or control condition, adherence to the intervention, completion of outcome measures and acceptability of treatment. METHODS AND ANALYSIS: We aim to recruit 48 participants randomised 50:50 to either the ACT intervention and treatment as usual (TAU), or TAU alone. ACT will be provided to participants in the treatment arm following completion of baseline outcome measures. Completion of these outcome measures will be repeated at 8, 16 and 26 weeks. The measures will assess several domains including psychological flexibility, subjective cognitive symptoms, mood and anxiety, health-related quality of life and functioning, healthcare utilisation, and satisfaction with care and participant-rated improvement. Fifteen participants will be selected for in-depth qualitative interviews about their experiences of living with FCD and of the ACT intervention. ETHICS AND DISSEMINATION: The study received a favourable opinion from the South East Scotland Research Ethics Committee 02 on 30 September 2022 (REC reference: 22/SS/0059). HRA approval was received on 1 November 2022 (IRAS 313730). The results will be published in full in an open-access journal. TRIAL REGISTRATION NUMBER: ISRCTN12939037.

Indexed as

Acceptance and Commitment TherapyCognitive DysfunctionFeasibility StudiesHumansOutcome Assessment, Health CareQuality of LifeDelirium & cognitive disordersNEUROLOGYPSYCHIATRY

Identifiers

PMID37169496
PMCPMC10186420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.